Number of lymph nodes associated with maximal reduction of long-term mortality risk in pathologic node-negative non-small cell lung cancer.
about
Measuring improvement in populations: implementing and evaluating successful change in lung cancer careTowards optimal pathologic staging of resectable non-small cell lung cancerDoes surgeon experience affect outcomes in pathologic stage I lung cancer?Size and histologic characteristics of lymph node material retrieved from tissue discarded after routine pathologic examination of lung cancer resection specimens.The impact of a novel lung gross dissection protocol on intrapulmonary lymph node retrieval from lung cancer resection specimens.Improving the pathologic evaluation of lung cancer resection specimens.Implementing effective and sustainable multidisciplinary clinical thoracic oncology programs.Pathologic Upstaging in Patients Undergoing Resection for Stage I Non-Small Cell Lung Cancer: Are There Modifiable Predictors?The impact of tumor size on the association of the extent of lymph node resection and survival in clinical stage I non-small cell lung cancer.Selection for adjuvant chemotherapy in completely resected stage I non-small cell lung cancer: external validation of a Chinese prognostic risk modelPrognostic value of lymph node ratio in patients with pathological N1 non-small cell lung cancer: a systematic review with meta-analysis.Survival following segmentectomy or lobectomy in elderly patients with early-stage lung cancer.Management of screening-detected stage I lung cancer.A Nomogram based on Inflammatory Factors C-Reactive Protein and Fibrinogen to Predict the Prognostic Value in Patients with Resected Non-Small Cell Lung CancerEffect of tumor size on prognosis of node-negative lung cancer with sufficient lymph node examination and no disease extension.Evolution in the Surgical Care of Patients With Non-Small Cell Lung Cancer in the Mid-South Quality of Surgical Resection Cohort.Prognostic Value of National Comprehensive Cancer Network Lung Cancer Resection Quality Criteria.Impact of Examined Lymph Node Count on Precise Staging and Long-Term Survival of Resected Non-Small-Cell Lung Cancer: A Population Study of the US SEER Database and a Chinese Multi-Institutional Registry.Rationale for a Minimum Number of Lymph Nodes Removed with Non-Small Cell Lung Cancer Resection: Correlating the Number of Nodes Removed with Survival in 98,970 Patients.Survival Implications of Variation in the Thoroughness of Pathologic Lymph Node Examination in American College of Surgeons Oncology Group Z0030 (Alliance).Quality Measures in Clinical Stage I Non-Small Cell Lung Cancer: Improved Performance Is Associated With Improved Survival.Missed Intrapulmonary Lymph Node Metastasis and Survival After Resection of Non-Small Cell Lung CancerSearching for the perfect lymphadenectomy.Can mathematics replace anatomy to establish recommendations in lung cancer surgery?Improving post-resection risk stratification in non-small cell lung cancer: 'wit, whither wander you?'Long-term outcomes of stage I NSCLC (≤3 cm) patients following segmentectomy are equivalent to lobectomy under analogous extent of lymph node removal: a PSM based analysis.Association of Pathologic Nodal Staging Quality With Survival Among Patients With Non-Small Cell Lung Cancer After Resection With Curative Intent.eComment. Radical vs selective lymphadenectomy for non-small-cell lung cancer: which is the optimal procedure?Lymph node assessment and survival: we still have work to do.[The Argument and Consensus of Lymphadenectomy on Lung Cancer Surgery].
P2860
Q26784096-F185C63D-9589-4721-8017-8DD7C56E74E3Q26991912-7807325D-8434-48CE-833C-9AD47C123723Q27308967-5F84EFBC-D68D-46AF-946A-383816C26DE8Q33645644-226F8260-1FA8-4120-B495-9FF77B9DD3A6Q33905550-DBA58B25-0A57-45E8-8D9B-69177728CAF1Q35996033-119943AB-F333-47A1-9A77-B9FE8EC2E5EBQ35996037-AF167B82-2E73-4F76-9B2F-AF0130D479B9Q36373131-E272C4CB-D38C-48C0-9DFE-48A1ADE2638BQ36494147-0E14D2EA-5130-419F-80FD-A12F68647EB0Q36540398-60E2C7D0-FED1-4329-97FC-F0D3C6CCF8E4Q37060723-25FEBB8A-5052-49D3-8640-F66158658D13Q37109941-467AA28A-DAD6-42BE-B8BD-CD965AE72575Q37411146-3EA4F17E-7FF9-4A70-BE79-9E554EBF64EAQ37738071-B4499623-6677-4644-A00E-AB3CB62631BDQ38388434-7C2769BF-E630-45F8-8752-82F1B82208BBQ38690568-DA19A2E2-830F-4FC5-8C8D-E1CFD6037CF1Q38862016-10CF6351-C7A4-41D4-9E05-2FBF20BA9392Q39060202-C224A0A9-6509-4FD2-B491-FA586280654FQ39484002-E1D7AB81-0C6E-4C3B-A697-D7894356912EQ39709228-326DD07A-FDF4-43C4-BEB1-81D7692451B7Q40567007-E06A161F-1614-4E46-8593-B2187142A085Q40717001-CA01DF82-39D0-4AC7-9866-FC4DF443C332Q42345615-AD5530F5-A06B-4048-BAF3-432DE8B3C0B7Q42362355-8FF24100-77DE-4AC7-B7AB-7AF5D7FD05E1Q42384614-ABE3E530-34E4-4EC5-A685-58AD5B27539FQ47140918-1D9E5BDB-DB5E-4F5E-990B-9C2B1025FFA1Q47917179-482D6FE7-6C69-470F-B920-FA5A62936C7FQ53488392-54802496-E7F7-4FFD-AC4A-CA668AE19A3FQ55261002-AE002833-5B05-48C2-BF19-43C56FBAEDABQ55518845-3A5D780D-B58C-425F-A042-1DA039978840
P2860
Number of lymph nodes associated with maximal reduction of long-term mortality risk in pathologic node-negative non-small cell lung cancer.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Number of lymph nodes associat ...... ve non-small cell lung cancer.
@en
Number of lymph nodes associat ...... ve non-small cell lung cancer.
@nl
type
label
Number of lymph nodes associat ...... ve non-small cell lung cancer.
@en
Number of lymph nodes associat ...... ve non-small cell lung cancer.
@nl
prefLabel
Number of lymph nodes associat ...... ve non-small cell lung cancer.
@en
Number of lymph nodes associat ...... ve non-small cell lung cancer.
@nl
P2093
P2860
P1476
Number of lymph nodes associat ...... ve non-small cell lung cancer.
@en
P2093
Obiageli Ogbata
Raymond U Osarogiagbon
P2860
P304
P356
10.1016/J.ATHORACSUR.2013.09.058
P407
P577
2013-11-20T00:00:00Z